Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 2b7f6fabon Nov 01, 2024 7:37pm
246 Views
Post# 36293218

RE:RE:RE:RE:Holding 0.35.

RE:RE:RE:RE:Holding 0.35.
Pandora wrote:
2b7f6fab wrote:
Beano349 wrote: 0.25, my by on the typo


I don't see any expiring soon.  Footnote 9 to the financials shows the warrants and when they expire.  In June 30, 2023 and September 7, 2023 there were .35 two year warrants issued.  And November 29, 2023 .28 five year warrants issued.


TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations, used to destroy various cancers, bacteria and viruses, safely and effectively, is pleased to announce that it has closed a non-brokered private placement offering (“Offering”) of units (“Units”). On closing, the Corporation issued an aggregate of 1,000,000 Units at a price of .25 per Unit for aggregate gross proceeds of approximately $250,000.

Each Unit consisted of one common share of the Company (“Common Share”) and one common share purchase warrant (“Warrant”). Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of .35 per share for a period of 24 months following the date of issuance.


Would that put these warrants ready to expire on Nov. 17, 2024? I did not see an extension but I could be wrong on that.
There was a batch from September 22, 2022 expiring on expiring on September 22, 2024 but they were extended to September 22, 2027.





Yes I do see those warrants on the schedule from the 1st Q, 2024 footnotes.  Just over a million warrants @ 35 cents.  I suspect they will be extended for 3 more years.  Below is the schedule, not sure how it will format correctly or not when this posts.  Highlighted in blue with 0.63 at the end indicating the remaining life from 3/31/2024 which is 7.5 months from 3/31/2024.  I removed the other warrants that expired back in August and have not added the warrants recently issued the past 7 months.

The following table summarizes information on the common share purchase warrants outstanding

Exercise
Price
Outstanding
Beginning of the
year
Expired During
the period
Exercised
During the
period
Granted During
the period
Outstanding
End of Period
Weighted Average
Remaining Contractual
Life (years)

$0.350 10,058,734 - - - 10,058,734 0.48
$0.350 1,002,700 - - - 1,002,700 0.63
$0.350 4,805,400 - - 4,805,400 1.25
$0.350 1,840,000 - - 1,840,000 1.44
$0.280 5,318,183 - - - 5,318,183 4.66
$0.250 - - - 6,670,836 6,670,836 4.85

<< Previous
Bullboard Posts
Next >>